Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

India seeks funds from Quad alliance to match China's vaccine push: source

Stock MarketsMar 08, 2021 04:56AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: Officials unload boxes containing vials of COVISHIELD vaccine outside a vaccination storage centre in Ahmedabad

By Rupam Jain and David Brunnstrom

NEW DELHI/WASHINGTON (Reuters) - India has urged the United States, Japan and Australia to invest in its vaccine production capacity, an Indian government source told Reuters, as the so-called Quad alliance tries to counter China's growing vaccine diplomacy.

Beijing has committed to provide at least 463 million doses of its home-made COVID-19 vaccines through exports and donations across the world from Asia to Africa, Europe and Latin America, according to Reuters calculations.

Two senior Indian officials said the Quad alliance, grouping the United States, Japan, Australia and India, was stepping up efforts to expand global vaccination to counter China's growing soft power. India, the world's biggest vaccine maker, believes it is best placed to steer the effort, they added.

Asked for comment, a U.S. State Department spokesperson did not refer to India's request for funds or to China but said Washington was deeply focused on expanding global vaccination, manufacturing and delivery.

"Secretary (Antony) Blinken spoke with his Quad counterparts on February 18 to discuss cooperation on COVID-19 response and recovery and climate change, among other issues," the official told Reuters.

There was no comment from the Australian government. But a government source said a global recovery from the COVID-19 pandemic was a policy priority for the country and its Quad partners. Australia is exploring a number of options to work with partners to enhance stability and prosperity in the region, the source said.

Japan's Foreign Minister Toshimitsu Motegi told a news conference on Friday that the four countries discussed the "necessity and importance of international cooperation to ensure equal access to vaccines for developing countries," at the February meeting, but nothing was decided.

An Indian foreign ministry spokesman did not respond to a request for comment.

One of the two Indian sources, an official who has direct knowledge of Quad alliance discussions, said the group had had several meetings about global vaccination.

"India has more vaccine options than any other Asian country at this point of time," said the source, declining to be named as he was not authorised to talk on the matter. "India expects members of the Quad alliance to pay to ramp up production.

A second Indian source said that at the February virtual meeting, the Quad countries discussed ways to "encourage alternative medical supply chains, thereby implying less dependency on China".

A top political advisory body in Beijing, the Chinese People's Political Consultative Conference, said concerns that China was using vaccines to sway other countries were "extremely narrow-minded."

China's purpose was to make vaccines available globally, the foreign ministry said.


Indian companies such as the Serum Institute of India (SII), Bharat Biotech, Biological E and Cadila Healthcare have the combined capacity to produce billions of doses of their own vaccines or contract-manufacture for others.

SII, the world's biggest single manufacturer, is producing the Oxford University-AstraZeneca vaccine for many countries and will soon start making the Novavax (NASDAQ:NVAX) shots in bulk.

India is also trying to sell a vaccine created by Bharat Biotech and the state-run Indian Council of Medical Research to 40 countries including Brazil, the Philippines and Zimbabwe. Bharat Biotech says it can make about 700 million doses of the shot a year.

Indian vaccine makers are also planning to produce more COVID-19 vaccines developed by the United States and Russia, including Johnson & Johnson (NYSE:JNJ).

A top Indian vaccine official told Reuters in January that the government had also held discussions with U.S. companies Pfizer Inc (NYSE:PFE) and Moderna (NASDAQ:MRNA) Inc about making their shots in India.

Serum's Novavax partnership holds "the key to the Quad’s diplomatic alliance in vaccines and push China out of regional vaccine sales", one of the Indian sources said.

"The focus is also on making sure the Quad alliance secures all the key markets for vaccines," he said.

Indian companies will also produce about 300 million doses of Russia's Sputnik-V vaccine, but the source said Washington was not keen on helping expand Moscow's clout in vaccines.

India seeks funds from Quad alliance to match China's vaccine push: source

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (2)
liama tew
liama tew Mar 09, 2021 12:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
talk is cheap... but who would cough up some cash? Modi please don't hold your breath for more than just talk talk
Michael Wong
Michael Wong Mar 08, 2021 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dreamy hopes by Indians that the other Quads can help them, they only will help themselves leaving the Indians high and dry.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email